期刊文献+

普拉克索的大鼠在体肠吸收 被引量:2

In situ Absorption Kinetics of Pramipexole in Rats Intestine
原文传递
导出
摘要 采用大鼠在体灌流法,以灌流液中剩余药物浓度为指标,考察普拉克索(1)在不同吸收部位的吸收动力学特征以及不同pH、不同药物浓度对1全肠段吸收的影响。结果显示,1在不同肠段的吸收速率常数(h-1)分别为:十二指肠0.295、结肠0.513、回肠0.480 h和空肠0.808 h。药物在大鼠全肠道内的吸收量随药物浓度的增大而升高,药物浓度和pH对吸收速率常数无显著性影响。1在肠道的吸收符合一级动力学特征,吸收机制为被动吸收。采用大鼠在体胃灌注法,以胃灌注液中药物前后浓度变化计算1在胃部吸收情况。结果表明1几乎不吸收。 The absorption kinetics of pramipexole(1) at different intestinal segments in rats and the influence of concentration and pH on the absorption kinetics were investigated with in situ perfusion.An HPLC method was developed to determine the concentrations of 1 in intestinal circulated fluid.The results showed that 1 can be absorbed in whole intestine.The absorption rate constants(Ka) at duodenum,colon,ileum and jejunum were 0.295 h-1,0.513 h-1,0.480 h-1 and 0.808 h-1,respectively.The absorptions in intestine were increased by the drug concentrations.The concentration of 1 and pH had no distinctive effect on the absorption kinetic.The absorption of 1 was in line with first-order kinetics with passive diffusion absorption mechanism.The absorption kinetics of stomach was obtained by the in situ perfusion method in rats.There is little absorption of 1 in stomach.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2011年第6期435-437,共3页 Chinese Journal of Pharmaceuticals
关键词 普拉克索 吸收速率常数 在体肠吸收 pramipexole absorption rate constant in situ absorption from intestine
  • 相关文献

参考文献6

  • 1夏玉凤,戴岳,孟庆玉,王强,仇玲玲.东莨菪素大鼠在体胃、小肠吸收动力学研究[J].中国中药杂志,2008,33(15):1890-1894. 被引量:8
  • 2郝正华,张丽锋,王锐利,张淑秋.甲硝唑大鼠肠吸收实验研究[J].中国药物与临床,2007,7(11):822-824. 被引量:2
  • 3Daniels CE.Pramipexole (MirapexR):abriefreview. http://clinicalcenter.nih.gov/phar/updates/Feb-Update01.pdf .
  • 4Stewart BH,Chan OH,Jezyk N,et al.Discrimination between drug candidates using models for evaluation of intestinal absorption. Advanced Drug Delivery Reviews . 1997
  • 5Factor,SA.Dopamine agonists. The Medical Clinics of North America . 1999
  • 6Pahwa R,Factor SA,Lyons KE,et al.Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology . 2006

二级参考文献12

  • 1乔志芬,孙江涛.甲硝唑的新用途[J].中国民间疗法,2004,12(6):61-62. 被引量:3
  • 2杨海秀,万红英,黄武军,黄庆.高效液相色谱测定甲硝唑注射液含量[J].江西中医学院学报,2005,17(3):70-70. 被引量:1
  • 3宋洪涛,谢彤,康鲁平,郭涛,陈大为,何仲贵.川芎嗪大鼠在体肠吸收动力学[J].中国医院药学杂志,2005,25(10):905-907. 被引量:17
  • 4张娴,邹豪,高申.咖啡因的大鼠在体肠吸收动力学研究[J].第二军医大学学报,2007,28(3):318-321. 被引量:5
  • 5毛凤斐 屠锡德 等.黄芩甙大鼠小肠吸收的研究[J].南京药学院学报,1984,15(1):61-61.
  • 6Kang T H, Pae H O, Jeong S J, et al. Scopoletin: an inducibal nitric oxide synthesis inhibitory active constituent from Artemisia feddei[J]. Planta Med, 1999,65:400.
  • 7Ding Z Q, Dai Yue, Wang Z T. Hypouricemic action of scopoletin arising from xanthine oxidase inhibition and uricosuric activity [ J ]. Planta Med, 2005,71(2) :183.
  • 8Stewart B H, Chan O H, Jezyk N, et al. Descrimination between drug candidates using models for evaluation of intestinal absorption [ J ]. Adv Drug Deliv Rev, 1997,23 (1) :27.
  • 9Edwards C. Physiology of the colorectal barrier[ J ]. Adv Drug Deliv Rev, 1997,23(2) :173.
  • 10Liu X L, Zhang L, Fu X L, et al. Effect of scopoletin on PC3 cell proliferation and apoptosis [ J ]. Acta Pharmacol Sin, 2001,22 (10) :928.

共引文献8

同被引文献29

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部